Spatial multi-omics expression of Neuronal System pathway
What the Clinical Evidence Shows While large-scale randomized controlled trials specifically measuring testosterone as a primary endpoint in tirzepatide users are still emerging, the available evidence is encouraging: The SURMOUNT trials demonstrated average weight losses of 15-22.5% of body weight, a degree of fat reduction strongly associated with testosterone recovery in men with obesity-related hypogonadism (Jastreboff et al., 2022, NEJM )
In fact, one study showed that just six months of growth hormone therapy, participants had improved lower body strength and this helped them improve their training performance: Our aim was to evaluate the effect of GH therapy on muscle strength in healthy men over 50 years old
If you experience minimal side effects and are losing weight steadily, your prescribed dose may advance from 2.5 mg to 5 mg, then 7.5 mg, 10 mg, 12.5 mg, and finally 15 mg